Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-002777-68Phase 4Completed
Phase 4, randomised trial of rosuvastatin in post-transplantation diabetes mellitus (PTDM), diabetes mellitus (DM) and dyslipidemia, sponsored by Cardiff and Vale University Health Board. Primary endpoint: Disposition index change. Started Jul 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-002777-68.